Sanofi (SNY) Net Cash Flow (2009 - 2026)

Sanofi has disclosed Net Cash Flow across 10 years of filings, most recently posting -$1.6 billion for Q1 2026.

• Net Cash Flow for Q1 2026 came in at -$1.6 billion, down 285.64% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.7 billion (up 64.65% YoY), and the FY2025 annual result was $167.6 million, up 114.4% from the prior year.
• Net Cash Flow came in at -$1.6 billion for Q1 2026 at Sanofi, down from -$1.2 billion in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $12.0 billion in Q4 2023 to a low of -$4.5 billion in Q2 2024.
• The 5-year median for Net Cash Flow is $2.0 billion (2024), against an average of $3.1 billion.
• Across the five-year window, Net Cash Flow slumped 605.0% in 2024 and surged 275.86% in 2025, its largest moves.
• Sanofi's Net Cash Flow stood at $11.2 billion in 2022, then climbed by 6.9% to $12.0 billion in 2023, then plunged by 103.03% to -$362.3 million in 2024, then sank by 221.33% to -$1.2 billion in 2025, then tumbled by 36.38% to -$1.6 billion in 2026.
• The last three Net Cash Flow figures came in at -$1.6 billion (Q1 2026), -$1.2 billion (Q4 2025), and $1.6 billion (Q3 2025), per Business Quant data.